PD-L1 targeted peptide demonstrates potent antitumor and immunomodulatory activity in cancer immunotherapy
BackgroundIn recent years, immunotherapy has been emerging as a promising alternative therapeutic method for cancer patients, offering potential benefits. The expression of PD-L1 by tumors can inhibit the T-cell response to the tumor and allow the tumo…